Rigel Pharmaceuticals

www.rigel.com
Profile Unclaimed

Rigel Pharmaceuticals Photos

Lobby
Rigel Building
Cafeteria

+ Add Photo

Rigel Pharmaceuticals Reviews

7 Reviews
3.3
7 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
(no image)
James M. Gower
5 Ratings
  •  

    Work experience

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee in South San Francisco, CA
    Current Employee - Anonymous Employee in South San Francisco, CA

    I have been working at Rigel Pharmaceuticals

    Pros

    Amazing people, Compensation, work life balance!

    Cons

    I can't think of one..

    Recommends
    Positive Outlook
    Approves of CEO

Rigel Pharmaceuticals Interviews

Interview Experience

Interview Experience

0%
100%
0%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Pharmaceuticals Interview

    Anonymous Employee
    Anonymous Employee
    Application Details

    I applied online. The process took 2 daysinterviewed at Rigel Pharmaceuticals in June 2010.

    Interview Details

    Very organized HR department.

    Interview Questions
    No Offer
    Neutral Experience
    Average Interview

Rigel Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.rigel.com
Headquarters South San Francisco, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public (RIGL)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

When immune systems attack, Rigel Pharmaceuticals wants to be there. The drug discovery and development firm focuses its research and development efforts on inflammatory/autoimmune, muscle, and metabolic diseases. Drugs in development include candidates for treating rheumatoid arthritis, psoriasis, muscle wasting, multiple sclerosis, and transplant rejection. Rigel prefers to collaborate with larger pharmaceutical companies in the development of its drug candidates. Rigel Pharmaceuticals went public through a $140 million IPO in 2011. The company intends to use the funds... More

Work at Rigel Pharmaceuticals? Share Your Experiences

Rigel Pharmaceuticals

 
Click to Rate
or